Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

Dairy-Tech Royal Innovation Dairy Award announces Actiphage as finalist

PBD Biotech is delighted that its novel Actiphage® testing technology has been shortlisted as a finalist for the Royal Dairy Innovation Award, to be presented at this year’s Dairy-Tech (6 February 2019).
  • January 31, 2019
  • Award, Dairy industry
  • award, dairy
Actiphage mycobacterial diagnostic

The Royal Dairy Innovation trophy and certificate are awarded for research and development in the field of dairy farming.

It goes to the most practical, relevant product or service, which is likely to be the most significant innovation for the future of dairying.

Actiphage is an innovative new test for the rapid detection of bovine TB, Johne’s disease and other mycobacterial infections. It has the potential to expedite food safety checks on milk and dairy products; revolutionise livestock disease management; and ease the burden on farmers, the industry and wider public.

Every year, Johne’s disease costs UK farmers and industry at least £13million and an increasing number of retailers are removing suppliers from their milk pool if they are not engaged in Johne’s disease testing.

Again in the UK alone, bovine TB results in almost 44,000 cattle slaughtered annually and an estimated cost to the taxpayer of £100million.

PBD Biotech’s Actiphage fits into current animal health testing practices and is the only diagnostic able to detect live mycobacteria – differentiating between infection and vaccination – that delivers results within 6 hours.

Originally developed as a tool for diagnosis of human TB, Actiphage has been optimised and developed to provide enhanced sensitivity and specificity for use in milk or blood samples.

Dairy-Tech organisers RABDF were inundated with entries for this year’s Royal Dairy Innovation Award and PBD Biotech was selected as one of three finalists alongside silage clamp specialist ARK Agriculture and animal health company Pruex Ltd.

PBD Biotech’s CEO Dr Berwyn Clarke will outline Actiphage’s patented technology and unique features to a panel of judges in the Innovation Hub at Dairy-Tech 2019. Event attendees are welcome to listen to the Award pitch, which will be taking place at 11.15am. Winners of the Royal Dairy Innovation Award will be announced later in the Innovation Hub at 3.50pm.

PBD Biotech will be exhibiting at Dairy-Tech 2019 in Hall 3, stand P41 (Floorplan, 1.8MB PDF)

Share:

Related posts

Loading...

Actiphage shows benefits for quality assurance in milk

January 26, 2022
Johne's Disease, is a wasting disease caused by MAP. A sensitive test for assessing milk samples would be a useful quality assurance tool.

Actiphage shows benefits for quality assurance in milk

January 26, 2022
Johne's Disease, is a wasting disease caused by MAP. A sensitive test for assessing milk samples would be a useful...
Mark Hammond, PBD Biotech CEO

Actiphage shortlisted for Vet Record Innovation Award 2021

February 11, 2021
Actiphage, the rapid diagnostic for Bovine TB and Johne's Disease, has been short-listed for the Vet Record Innovation Award 2021. The award is for an innovation that has brought about – or has the potential to bring about – a...
Mark Hammond, PBD Biotech CEO

Actiphage shortlisted for Vet Record Innovation Award 2021

February 11, 2021
Actiphage, the rapid diagnostic for Bovine TB and Johne's Disease, has been short-listed for the Vet Record Innovation Award 2021....
bury_free_press_business_awards_2019

PBD Biotech’s new TB test wins West Suffolk Award for Innovation

October 14, 2019
PBD Biotech has been awarded The West Suffolk Award for Innovation for its rapid accurate blood test, which, by detecting TB in humans and animals at early stage, will help to eradicate this devastating disease.
bury_free_press_business_awards_2019

PBD Biotech’s new TB test wins West Suffolk Award for Innovation

October 14, 2019
PBD Biotech has been awarded The West Suffolk Award for Innovation for its rapid accurate blood test, which, by detecting...
Ben Swift with cows

11 September 2019

PBD Biotech to feature in Innovation Zone at UK Dairy Day 2019

August 8, 2019
Dairy farmers and producers interested in implementing an effective disease management strategy for bovine Tuberculosis (bTB) and Johne’s disease will be able to find out more at PBD Biotech’s stand in the Innovation Zone at UK Dairy Day 2019 on...
Ben Swift with cows

11 September 2019

PBD Biotech to feature in Innovation Zone at UK Dairy Day 2019

August 8, 2019
Dairy farmers and producers interested in implementing an effective disease management strategy for bovine Tuberculosis (bTB) and Johne’s disease will...
1 2 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More